Zevra Therapeutics Q3 EPS $0.26 Beats $0.16 Estimate, Sales $37.756M Beat $37.079M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.16 by 62.5 percent. This is a 2700 percent increase over losses of $(0.01) per share from
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.16 by 62.5 percent. This is a 2700 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $37.756 million which beat the analyst consensus estimate of $37.079 million by 1.83 percent. This is a 44.86 percent increase over sales of $26.063 million the same period last year.